Diabetic Retinopathy

This diagnostic/prognostic study uses data and color fundus photographs from a randomized clinical trial involving patients undergoing treatment of diabetic macular edema to enable artificial intelligence systems to estimate best-corrected visual acuity and to evaluate the accuracy of those estimates.

This cohort study evaluates the risks of adverse events associated with intravitreal anti–vascular endothelial growth factor injections in individuals with diabetes.

This cohort study investigates the association of the deep learning–based diabetic macular ischemia with the subsequent risk of diabetic retinopathy progression, diabetic macular edema development, and visual acuity deterioration.

This cohort study investigates the rates of incidence and progression for diabetic retinopathy in American Indian and Alaska Native individuals.

This economic evaluation determines the cost-effectiveness of aflibercept monotherapy vs bevacizumab first, then aflibercept for suboptimal response, in treating patients with diabetic macular edema.

This systematic review and meta-analysis investigates the outcomes of pars plana vitrectomy for the treatment of diabetic tractional retinal detachment.

This Viewpoint discusses new treatment approaches for diabetic macular edema.

This case-control study investigates the association of tractional retinal detachment in proliferative diabetic retinopathy with intravitreal injections compared with other treatment regimens.

This case report describes a 48-year-old man with acquired nonpigmented vitreous cyst associated with regressed diabetic neovascularization.

This study repeats previous meta-analyses of the prevalence and progression of diabetic retinopathy in pregnant populations with preexisting diabetes.

This cross-sectional study evaluates the representation of racial and ethnic minority groups in randomized clinical trials of diabetic macular edema and retinal vein occlusion compared with US Census data.

This cohort study analyzes ultra-widefield imaging data to determine whether predominantly peripheral lesions are associated with increased disease worsening beyond the risk associated with baseline Diabetic Retinopathy Severity Scale score.

This cohort study analyzes 4 years of longitudinal data to assess worsening in Diabetic Retinopathy Severity Score in association with changes in retinal nonperfusion from baseline as captured by ultra-widefield fluorescein angiography.